Glaucoma Study


A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Performance of the AqueSys Implant in Patients with Refractory Glaucoma


Johnson Sandra, M

The purpose of this study is to evaluate the investigational device, the AqueSys Microfistula Implant, for its safety and ability to decrease intraocular pressure (IOP) in eyes with refractory glaucoma, which have previously failed a glaucoma procedure and have high IOP on maximally tolerated IOP-lowering medications. Key Eligibility Criteria: 1. At least 45 years of age 2. Diagnosis of primary open-angle glaucoma in the potential study eye 3. Refractory glaucoma in the study eye (having elevated IOP while on maximally tolerated IOP-lowering medications and having undergone a prior incisional glaucoma surgery or cilioablative procedure) 4. Intraocular pressure = 22 mmHg and = 35 mmHg in the study eye For more information about this study please contact the Clinical Research Coordinator, Kristina Holbrook, at: (434) 243-2852 or . The principal investigator is Sandra M. Johnson, M.D

Ophthalmology Research





No Compensation

Kristina Holbrook